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A Reentrant Loop Domain in the Glutamate
Carrier EAAT1 Participates in Substrate
Binding and Translocation
1992; Pines et al., 1992; Storck et al., 1992; Arriza et al.,
1994, 1997; Fairman et al., 1995), the structural elements
of the carrier that contribute to ion binding, substrate
transport, and anion permeation have not yet been re-
solved. Several lines of evidence point to the functional
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importance of a putative membrane-spanning regionPortland, Oregon 97201
(TM) from residues P392 through Q415 (TM 8 by hydrop-
athy analysis). This highly conserved region contains a
motif (AAXFIAQ) that is found in all members of thisSummary
carrier family, including an invertebrate sodium-depen-
dent EAA carrier from D. melanogaster (dEAAT) (SealTo investigate the structural determinants underlying
et al., 1998), a proton-dependent glutamate transportertransport by the glutamate transporter EAAT1, we mu-
from E. coli (GltP) (Tolner et al., 1992), and a dicarboxy-tated each of 24 highly conserved residues (P392 to
late carrier from R. meliloti (DctA) (Bolton et al., 1986).Q415) to cysteine. A majority of these substituted cys-
Experimental evidence to support the importance of thisteines react with the sulfhydryl-modifying reagent
region in substrate and cotransported ion interactionsMTSEA, suggesting that they reside in an aqueous
has come from studies of chimeric and site-directedenvironment. The impermeant reagents MTSES and
mutant transporters. Chimeras made between kainateMTSET react with residues at each end of the domain
sensitive (EAAT2) and insensitive (EAAT1) subtypes of(A395C and A414C), supporting a model that places
the human EAAT carriers demonstrated that kainate, athese residues near the extracellular surface. Sub-
constrained analog of glutamate that acts as a competi-strates and inhibitors block the reaction between MTS
tive inhibitor, appears to interact with this domain (Van-derivatives and A395C, and the cosubstrate, sodium,
denberg et al., 1995). Additional evidence highlightingslows reaction of MTSEA with Y405C and E406C. From
the importance of this region has come from the evalua-these results, we propose that this domain forms a
tion of site-directed mutants of the GLT-1 transporterreentrant membrane loop at the cell surface and may
(rat homolog of EAAT2) that appear to influence sub-comprise part of the translocation pore for substrates
strate interactions with the carrier, including D398, Y403,and cotransported ions.
and E404 (Pines et al., 1995; Kavanaugh et al., 1997;
Zhang et al., 1998). Finally, although several groups have
Introduction investigated the transmembrane topologies for mem-
bers of this family, the C-terminal half of the carrier,
Sodium-dependent glutamate transporters contribute to which includes this domain, remains ambiguous (Jord-
the process of excitatory transmission by buffering and ing and Puhler, 1993; Slotboom et al., 1996; Wahle and
removing synaptically released glutamate (Mennerick Stoffel, 1996). For these reasons, we have systematically
and Zorumski, 1994; Tong and Jahr, 1994; Otis et al., evaluated 24 amino acid residues from P392 to Q415 in
1996; Diamond and Jahr, 1997). By maintaining extracel- the human EAAT1 transporter by the substituted cyste-
lular glutamate concentrations at low micromolar levels, ine accessibility method (SCAM) (Akabas et al., 1992,
they also contribute to the prevention of excitotoxic 1994) to examine their accessibility to the extracellular
mechanisms of cell death (Szatkowski and Attwell, milieu and for their contributions to the binding and/or
1994). The electrogenic uptake of excitatory amino acids translocation of carrier substrates.
(EAAs) by these carriers is coupled to the electrochemi- We employed SCAM because, unlike typical mutagen-
cal gradient of sodium ions (Kanner and Sharon, 1978). esis paradigms, this approach allows for transporter
Although the transport of substrates appears to occur function to be evaluated both before and after modifica-
by a classical carrier-mediated cotransport mechanism, tion of specific residues with cysteine-reactive reagents.
application of substrates to these carriers also appears Interactions between individual residues and substrates
to elicit a chloride conductance that is thermodynami- of the transporter can be examined by determining
cally uncoupled from substrate movement (Eliasof and whether the presence of EAA or ion cosubstrates alters
Werblin, 1993; Fairman et al., 1995; Picaud et al., 1995; the kinetics of the reaction of cysteine residues with
Wadiche et al., 1995). The ability to mediate a substrate- thiol-modifying reagents. Methanethiosulfonate (MTS)
activated chloride conductance suggests that these derivatives react rapidly and specifically with the sulfhy-
molecules may also modulate cell excitability (Picaud dryl moiety of the cysteine residue to create a covalent
et al., 1995). Thus, as mediators of both transport and attachment that introduces either a positively charged
ion channel activities, EAA transporters (EAATs) have ethylamine (MTSEA), a negatively charged ethylsulfo-
the potential to modulate synaptic transmission through nate (MTSES), or a bulkier ethyl trimethylammonium
the simultaneous execution of multiple functions. (MTSET) group (Akabas et al., 1992). These compounds
Although several members of the EAAT family have have been shown to react at least a billion times faster
been cloned and characterized (Kanai and Hediger, with the unprotonated form of the sulfhydryl moiety
(Roberts et al., 1986). Because the ionized, or more
reactive, form is strongly disfavored by the low dialectric³ To whom correspondence should be addressed (e-mail: amaras@
ohsu.edu). constant of the lipid environment, it is assumed that
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Figure 1. Location of the Cysteine Substitu-
tions in EAAT1
(A) Topological model of the human EAAT1
carrier. Hydrophobic stretches are drawn as
numbered membrane-associated domains
with the eighth TM configured as a reentrant
membrane loop. Arrows indicate the three en-
dogenous cysteine residues (C186S, C252A,
and C375G) conservatively mutated to create
the Cys(2) carrier and the residues P392
through Q415, which span the domain ana-
lyzed by SCAM.
(B) Alignment of the residues of TM 8 of the
cloned human EAATs 1±5, which were indi-
vidually substituted to cysteine in the Cys(2)
form of EAAT1. Residues in white boxes are
not conserved with EAAT1.
(C) Cell surface expression of EAAT mutants
in COS-7 cells. Western blots of transiently
expressed carriers labeled with membrane-
impermeant NHS-biotin in intact COS-7 cells.
Blots were probed with a polyclonal antibody
raised to the C terminus of EAAT1. CMV de-
notes the vector-transfected control. EAAT1
expressed in COS-7 cells appears as two
bands that run at z120 kDa and 66 kDa.
modification of the side chains occurs in an aqueous Cys(2) carrier with similar transport properties. An ap-
parent affinity value (Km) for L-Glu transport was obtainedenvironment (Karlin and Akabas, 1998).
In this study, we show that one residue at each end by measuring the uptake of radiolabeled L-Glu in COS-7
cells. As shown in Table 1, a slightly lower Km value wasof the scanned region, A395C and A414C, is accessible
to both of the membrane-impermeant reagents MTSES observed for the Cys(2) carrier (Km 5 37 mM 6 3 mM;
and MTSET, that membrane-permeant MTSEA inhibits
the transport activity of a majority of the cysteine substi-
tution mutants, and that the modification rates of three Table 1. Apparent Affinity Values of L-glutamate Transport by
the Single Cysteine Mutants Expressed in COS-7 Cellscysteine mutants, A395C, Y405C, and E406C, are altered
by substrates and cotransported ions. These results Mutant Km (mM) n Mutant Km (mM) n
suggest that, at the cell surface, this region of the carrier
EAAT1 70 1/2 5 3 A403C 35 1/2 4 2has the topological configuration of a reentrant loop.
Cys(2) 37 1/2 3 9 L404C 26 1/2 11 2
Like the reentrant loops found in a number of ion chan- P392C 46 1/2 6 2 Y405C 36 1/2 4 2
nels, residues in this domain may participate in forming V393C 26 1/2 5 2 E406C 27 1/2 7 3
an aqueous pore through which substrates and cotrans- G394C N.F. A407C 39 1/2 5 3
A395C 39 1/2 6 3 L408C 43 1/2 8 4ported ions travel and may directly facilitate their binding
T396C 58 1/2 11 3 A409C 39 1/2 4 2and/or translocation during the transport cycle.
I397C 49 1/2 4 3 A410C 38 1/2 11 3
N398C N.F. I411C 46 1/2 12 2
Results M399C N.F. F412C N.F.
D400C N.F. I413C N.F.
Although application of the MTS derivatives to the wild- G401C N.F. A414C 44 1/2 6 2
T402C N.F. Q415C N.F.type EAAT1 transporter did not alter its transport activity
(data not shown), a carrier devoid of cysteine residues Each transporter was transiently expressed in COS-7 cells and the
(Cys[2]) eliminated the possibility that one or more en- accumulation of radiolabeled L-glutamate measured at concentra-
tions ranging from 1 mm to 1000 mM. Km values were derived by fittingdogenous cysteine residues would become reactive
the data to the Michaelis-Menten equation. Errors are presented aswhen other residues were mutated. Conservative substi-
SEM for n independent determinations. Nonfunctional carriers aretutions for the three endogenous cysteine residues,
denoted by N.F.
C186S, C252A, and C375G (Figure 1A), resulted in a
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n 5 9) than for the EAAT1 carrier (Km 5 70 mM 6 5 mM; are thought to be membrane impermeant, MTSEA per-
meates the membrane under some conditions (Holm-n 5 3). This difference was also observed when the
potency to elicit substrate-activated transport currents gren et al., 1996). Regardless of whether they cross the
membrane, reaction of these compounds with cysteine(EC50) was measured for the Cys(2) transporter (EC50 5
8 mM 6 2 mM; n 5 4) and the EAAT1 transporter (EC50 5 residues only occurs to an appreciable extent when the
sulfhydryl moiety is in an aqueous environment. There-20 mM 6 2 mM; n 5 4) using the two-electrode voltage-
clamp technique in the Xenopus oocyte expression sys- fore, we assume that a cysteine side chain reactive with
MTSEA faces either the extracellular or intracellular mi-tem. Examination of individual cysteine mutants in oo-
cytes indicated that the higher apparent affinity is linked lieu or an aqueous filled intramembrane compartment
such as a pore, while a cysteine side chain reactive withwith the C375G mutation because the C186S (EC50 5
21 mM 6 4 mM; n 5 4) and C252A (EC50 5 25 mM 6 5 MTSES or MTSET faces either the extracellular milieu
or an aqueous intramembrane compartment, accessiblemM; n 5 4) mutants have EC50 values similar to EAAT1,
while the C375G (EC50 5 7 mM 6 1 mM; n 5 4) mutant has from the extracellular space (Javitch, 1998).
While no change in uptake was observed after thean EC50 value closer to the Cys(2) carrier. No differences
were observed between the wild-type and Cys(2) carri- application of 2.5 mM MTSEA to the Cys(2) carrier,
significant inhibition was observed for all of the cysteineers in either the current±voltage relationships deter-
mined in oocytes nor in the maximum velocity (Vmax) substituted carriers, except A407C, L408C, and I411C
(Figure 2A). As shown in Figure 2B, a lower concentrationof radiolabeled L-Glu uptake in COS-7 cells (data not
shown). Also, the plasma membrane levels of the two of MTSEA (1 mM) still markedly inhibited L-Glu transport
by the P392C through I397C, Y405C, and A414C trans-proteins were comparable when they were evaluated in
COS-7 cells using a cell surface biotinylation protocol porters. The functional effects induced by the extracellu-
lar application of the membrane-impermeant MTS deriv-(data not shown; see Experimental Procedures). Thus,
the activity of the Cys(2) transporter appears to be simi- atives MTSES and MTSET were also evaluated. MTSET
is positively charged and has a trimethylammoniumlar to the wild-type EAAT1 and, therefore, provides an
excellent background in which to introduce single cyste- group, which is bulkier than the amine of MTSEA. At 1
mM, this reagent significantly inhibited the uptake ofine substitutions for analysis by SCAM.
the A395C and A414C transporters (Figure 2C). MTSES
(10 mM), a negatively charged molecule that has a simi-
Cysteine Substitution Mutants Show Transport lar size to MTSET, also significantly inhibited the uptake
Activity Similar to Cys(2) of L-Glu by these two transporters (Figure 2D). The posi-
To evaluate whether residues in the eighth hydrophobic tioning of these two reactive residues at opposite ends
domain of the carrier (Figure 1A) interact with substrates of this relatively hydrophobic domain, which has been
or cotransported ions, 24 consecutive amino acid resi- implicated in the binding of intracellular potassium ions
dues (P392 through Q415; Figure 1B) were individually (Pines et al., 1995; Kavanaugh et al., 1997), suggests
substituted with cysteine using the Cys(2) carrier as the that this region could form a reentrant loop, similar to
template. Functional characterization of each mutant what has been postulated for a number of proteins that
transporter was determined by measuring the accumu- transport ions across cell membranes (see Discussion).
lation of radiolabeled L-Glu in COS-7 cells. Fifteen of
the twenty-four mutants show significant accumulation
Effects of MTS Derivatives on Transport by A414Cof L-Glu over that observed for mock transfected cells,
Although all three of the MTS derivatives tested appearand all have Km values for L-Glu transport that are similar
to inhibit transport by the A414C carrier, the percentto the Cys(2) carrier (Table 1). Vmax values for the func-
of inhibition conferred by a maximal concentration oftional mutants were greater than 20% of the Vmax of the
MTSEA is less than with MTSET or MTSES (Figure 2).Cys(2) carrier (data not shown). To determine whether
Initially it was observed that application of 2.5 mMthe loss of transport activity observed with nine of the
MTSEA (37% 6 3%; n 5 5) reduced transport by approx-cysteine substitution mutants was due to an absence of
imately the same percentage as with 1 mM MTSEAthe transporter at the cell surface, the plasma membrane
(35% 6 4%; n 5 3) (Figure 2). To confirm that the A414Clevels of the mutant proteins were evaluated by cell
carrier is maximally inhibited by these concentrations,surface biotinylation. Four of the nine mutants appear
cells expressing the transporter were incubated withto be severely reduced at or absent from the plasma
additional concentrations of MTSEA (0.5 mM to 5 mM).membrane (G401C, F412C, I413C, and Q415C), while
As shown in Figure 3A, the percent inhibition of L-Gluthe remaining five mutants are expressed at levels com-
uptake observed was approximately the same at all con-parable to or slightly lower than the Cys(2) carrier
centrations tested and was never greater than 50%.(G394C, N398C, M399C, D400C, T402C; Figure 1C).
These findings imply that while MTSES and MTSET can
abolish greater than 90% of the L-Glu transport activity,
the maximum inhibition conferred by MTSEA at this resi-Extracellularly Applied MTS Derivatives React
with the Cysteine Substitutions due appears to be only 30%±40%. Using concentrations
of MTSEA ranging from 0.05 mM to 2.5 mM, a secondThe accessibility of each cysteine residue to an aqueous
milieu was determined in the 15 functional mutants by order rate constant of 104 6 15 M21s21 (n 5 2) was
calculated. To better understand the nature of the inter-measuring the uptake of radiolabeled L-Glu with and
without the extracellular application of the MTS deriva- action of the MTS derivatives with the cysteine at this
position, the effects of two neutral MTS derivatives weretives in intact COS-7 cells. While MTSES and MTSET
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Figure 2. Inhibition of L-Glu Transport by Co-
valent Modification of MTS Derivatives
COS-7 cells transiently transfected with Cys(2)
or the various mutants were incubated with
and without either 2.5 mM MTSEA (A), 1 mM
MTSEA (B), 1 mM MTSET (C), or 10 mM
MTSES (D). L-Glu uptake is expressed as the
percent inhibition of transport. Black bars
show residues that were inhibited to a signifi-
cantly greater extent than the Cys(2) carrier
(p , 0.05; one-way ANOVA). Each bar is the
mean 6 SEM from three or more independent
experiments. Mutants unable to transport
L-Glu are denoted by either an open circle
(not at cell surface) or closed circle (at cell
surface).
evaluated. MMTS (methyl methanethiosulfonate) with a reflects that observed with the test compound alone, it
implies that the compound was able to react to comple-single methyl group is small, while MTSACE (2-[amino-
carbonyl]ethyl methanethiosulfonate) is approximately tion with the residue and thus prevent subsequent modi-
fication by MTSES. This result was observed with eachthe same size as MTSET and MTSES. Maximal concen-
trations of these compounds appeared to inhibit trans- compound tested, indicating that they react to comple-
tion with the same cysteine side chains as MTSES. Thus,port of L-Glu by 16% 6 4% (n 5 5) and 64% 6 6% (n 5
2), respectively (Figure 3B). These data suggest that it appears that the size and possibly the charge of the
modifying group, rather than limitations in the ability ofA414C is readily accessible to the extracellular aqueous
environment and that the extent of the inhibition ob- the compound to react to completion with the residue,
determine the reduction in L-Glu transport by the A414Cserved depends on the chemical properties of the MTS
derivative used. carrier.
Inhibition of transport by these compounds may de-
pend on their ability to react to completion with the Carrier Substrates Protect Engineered Cysteine
Residues from Modificationcysteine side chain, or it may depend on the size and/
or electrostatic properties of the substituent once it has by the MTS Derivatives
To examine whether substrates of the carrier could pro-been linked to the sulfhydryl group. To examine this,
cells expressing the A414C carrier were incubated with tect the reactive cysteine substitutions from modifica-
tion by the MTS derivatives, a saturating concentrationa saturating concentration of MTSEA (2.5 mM; Figure
3C), MMTS (1 mM; Figure 3D), or MTSACE (2.5 mM; of L-Glu was incubated with each compound (Figure 4).
MTSET (1 mM), MTSES (10 mM), or MTSEA (2.5 mM)Figure 3E) alone or followed by incubation with MTSES.
If, after the sequential application of both the test com- was applied in the presence and absence of 10 mM
L-Glu. Transport of L-Glu was plotted as the percentpound and MTSES, the fractional inhibition of uptake
Cysteine-Scanning Mutagenesis of EAAT1
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Figure 3. MTS Derivatives Differentially Af-
fect A414C Transport Activity
(A) Cells expressing the A414C transporter
were incubated with concentrations of MTSEA
(0.5 mM to 5 mM). L-Glu uptake is plotted as
the percent inhibition of uptake, and the data
presented are the means 6 SEM of three to
five independent experiments.
(B) Cells expressing the A414C transporter
were incubated with 1 mM MMTS, 2.5 mM
MTSEA, 10 mM MTSES, 1 mM MTSET, or 2.5
mM MTSACE. L-Glu uptake is plotted as the
percent inhibition of uptake and the data pre-
sented are the means 6 SEM of two to seven
independent experiments done in triplicate.
(C) Cells expressing the A414C transporter
were incubated with 2.5 mM MTSEA or 10
mM MTSES alone or with 2.5 mM MTSEA
followed by incubation with 10 mM MTSES.
L-Glu uptake is plotted as the percent inhibi-
tion of uptake, and the data presented are
the means 6 SEM of three independent ex-
periments done in triplicate.
(D) Same as in (C) but with 1 mM MMTS rather
than MTSEA.
(E) Same as in (C) but with 2.5 mM MTSACE
rather than MTSEA.
inhibition of uptake. Although both the A395C and A414C 0.3; n 5 4) than when the experiment was carried out
in the absence of L-Glu (IC50 5 0.5 6 0.1; n 5 4).transporters are greatly inhibited by the membrane-
impermeant MTS derivatives, only the A395C carrier was Because the second order rate constant is a function
of both the concentration of the reagent and the durationprotected from MTSES and MTSET by the presence
of substrate (Figure 4A). Interestingly, when the A395C of the incubation, the ability of L-Glu to protect A395C
in the presence of 2.5 mM MTSEA was also examinedcarrier was incubated with a relatively high concentra-
tion of MTSEA (2.5 mM), L-Glu did not effectively block as a function of time (Figure 4E). As expected, a similar
relationship was observed between the transport activ-the reaction between the cysteine residue and the modi-
fying reagent. However, as shown in subsequent experi- ity and exposure to MTSEA. In the absence of L-Glu,
MTSEA inhibited transport completely and with a sec-ments, a significant protective effect of substrates could
be observed with lower concentrations of MTSEA. ond order rate constant of 12 6 2 M21s21 (n 5 3). In the
presence of L-Glu, the transport activity diminished overTo further examine the protective effect of L-Glu on
the A395C transporter, concentration curves of each time and was abolished by 5 min. These data also could
not be fit to generate a second order rate constant;MTS derivative were carried out with and without a satu-
rating concentration of L-Glu. In the absence of L-Glu, however, the modification reaction was slowed more
than 5-fold by L-Glu (t0.5 . 200 s versus t0.5 5 25 6 5 s;increasing concentrations of MTSET (Figure 4B), MTSES
(Figure 4C), and MTSEA (Figure 4D) led to complete n 5 3). Therefore, a saturating concentration of L-Glu
protects the A395C residue from modification by highinhibition of the transport activity. The fraction of uptake
activity was plotted as a function of the MTS derivative concentrations of the membrane-impermeant com-
pounds MTSES and MTSET, as well as from MTSEA atconcentration and fitted to generate second order rate
constants (kMTSET 5 3.0 6 0.3 M21s21, kMTSES 5 0.72 6 0.05 concentrations less than z1.3 mM. The unique behavior
of MTSEA on the transport activity of the A395C carrierM21s21, and kMTSEA 5 10 6 2 M21s21). L-Glu prevented
the inhibition of transport by MTSET and MTSES at con- in the presence of L-Glu may be because MTSEA can
be membrane permeant under some conditions (seecentrations several-fold above those required to abolish
the transport activity (10 mM and 50 mM, respectively). Discussion) (Holmgren, et al., 1996). L-Glu (10 mM) had
no effect on the MTSEA modification observed with theThis is in contrast to what is observed with MTSEA.
In the presence of L-Glu, the level of transport activity other cysteine substituted carriers (data not shown).
remained high until the concentration of MTSEA reached
z1.3 mM, at which point it decreased sharply and was Protection Occurs with a Physiologically
Relevant Concentration of L-Gluabolished by 2.5 mM. Although these data could not be
fit to generate a second order rate constant, the IC50 for We also examined whether L-Glu limits modification of
the A395C carrier at concentrations of L-Glu that areMTSEA was approximately 3-fold greater (IC50 5 1.8 6
Neuron
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Figure 4. Effect of L-Glu on Thiol Modifica-
tion of the A395C Transporter
(A) COS-7 cells transiently transfected with
the A395C transporter were incubated with 1
mM MTSET, 10 mM MTSES, or 2.5 mM
MTSEA in the presence (white bars) and ab-
sence (black bars) of 10 mM L-Glu. Data are
plotted as percent inhibition of L-Glu uptake.
(B) Cells expressing the A395C transporter
were incubated with concentrations of
MTSET ranging from 0.1 mM to 10 mM in the
presence (squares) and absence (triangles)
of 10 mM L-Glu. Data are plotted as the frac-
tion of L-Glu uptake as a function of the
MTSET concentration and are the means 6
SD of two independent experiments done in
triplicate.
(C) Cells expressing the A395C transporter
were incubated with concentrations of MTSES
ranging from 1 mM to 50 mM in the presence
(squares) and absence (triangles) of 10 mM
L-Glu. Data are plotted as the fraction of L-Glu
uptake as a function of the MTSES concentra-
tion and are the means 6 SD of two indepen-
dent experiments done in triplicate.
(D) Cells expressing the A395C transporter
were incubated with concentrations of
MTSEA ranging from 0 mM to 2.5 mM in the
presence (squares) and absence (triangles)
of 10 mM L-Glu. Data are plotted as the frac-
tion of L-Glu uptake as a function of MTSEA
concentration and are the means 6 SD of four
independent experiments done in triplicate.
(E) Cells expressing the A395C transporter
were incubated with 2.5 mM MTSEA in the
presence (squares) and absence (triangles)
of 10 mM L-Glu for times ranging from 10 s
to 300 s. Data are plotted as the fraction of
L-Glu uptake as a function time and are the
means 6 SEM for three independent experi-
ments done in triplicate.
physiologically relevant to the transport mechanism. the ability to induce conformational changes in the car-
rier. However, because they are not translocated, theCells expressing the A395C carrier were incubated with
a low concentration of MTSEA (0.25 mM) and concentra- profile of conformation states and binding events that
occur with these compounds are likely to be more re-tions of L-Glu ranging from 0 mm to 1000 mM. Radiola-
beled L-Glu uptake was measured and fitted to the Mi- stricted than with substrates. Cells were incubated with
10 mM MTSES and concentrations of DL-TBOA rangingchaelis-Menten equation (Figure 5A). The calculated
EC50 value is similar to the Km value for L-Glu uptake by from 1 mm to 1000 mM. DL-TBOA was able to protect
the A395C residue from modification by MTSES with anthis carrier in COS-7 cells (EC50 5 35 mM 6 5 mM, n 5
3; Km 5 37 mM 6 3 mM, n 5 9). To determine whether EC50 of 29 mm 6 8 mM (n 5 3; Figure 5B), a value similar
to its affinity to inhibit the uptake of L-Glu by this carrierthis relationship holds true for other MTS derivatives,
we also carried out the experiment with MTSES and (IC50 of 19 mm 6 4 mM; n 5 2). As was observed with
L-Glu, DL-TBOA also completely blocked modificationobtained a similar EC50 value (data not shown). The simi-
larity in the affinity values for the protection mechanism by MTSET, but not by MTSEA (data not shown). These
results are consistent with protection of the A395Cand the uptake activity suggests that protection of the
residue occurs at a step within the transport process. transporter taking place at a step in the transport cycle
closely linked to L-Glu binding.
Binding of the Competitive, Nontransported
Inhibitor DL-TBOA Also Blocks Modification Protection of the A395C Residue by L-Glu
Is Not Temperature Sensitiveof the A395C Residue
To further explore the relationship between A395C and We took advantage of the temperature dependence of
transport to help identify at which step(s) in the transporttransport, we tested whether a high-affinity, nontrans-
ported, competitive inhibitor of EAAT1, DL-threo-b- cycle L-Glu acts to block the modification of A395C.
L-Glu transport is highly temperature sensitive such thatBenzyloxyaspartate (DL-TBOA) (Shimamoto et al., 1998),
could protect the A395C residue from modification at temperatures approaching 08C, translocation is se-
verely reduced (Stallcup et al., 1979), although bindingby MTSES. Nontransported competitive inhibitors are
thought to bind at substrate binding sites and may have of substrate remains relatively unaffected (Wadiche and
Cysteine-Scanning Mutagenesis of EAAT1
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Kavanaugh, 1998). The observed temperature depen-
dence is consistent with protein conformational changes
required for translocation (Wadiche and Kavanaugh,
1998). Therefore, we tested the ability of L-Glu to protect
the A395C residue from modification at a temperature
that severely impairs substrate translocation (Figure 5C).
A time course for the modification of the A395C carrier
by 10 mM MTSES was carried out in the presence and
absence of 10 mM L-Glu, at 228C and at 28C±48C. At
228C, MTSES irreversibly inhibited the transport activity
of the carrier with a reaction rate constant of 0.80 6
0.05 M21s21 (n 5 3) in the absence of L-Glu and at a rate
approximately 20-fold slower in the presence of L-Glu,
k 5 0.047 6 0.009 M21s21 (n 5 3). This result is consistent
with the ability of L-Glu to protect the residue from modi-
fication over a range of MTSES concentrations (see Fig-
ure 4C). At 28C±48C and in absence of L-Glu, the reactiv-
ity rate (k 5 0.21 6 0.03 M21s21; n 5 3) was 25% of the
rate measured at 228C. The reduction in the reaction
rate at the lower temperature (Q10 ≈ 2) is consistent with
previous estimates of the temperature dependence of
the rate of the chemical reaction between the sulfhydryl
group and the MTS derivative (Q10 5 2, A. Karlin, personal
communication). As was observed at 228C, L-Glu com-
pletely protected A395C from modification when the
reaction was carried out at 28C±48C (k 5 0.033 6 0.003
M21s21; n 5 3). Thus, L-Glu protects the residue from
modification when the reaction is carried out at tempera-
tures that dramatically slow the transport cycle, sug-
gesting that block by L-Glu occurs at a step prior to the
temperature-sensitive conformational changes that the
carrier undergoes as a result of its interaction with sub-
strate.
Sodium Ions Affect the Modification Rate
of Two Cysteine Substitution Mutants
The L-Glu transport is thought to proceed through the
ordered binding of substrates, with sodium binding be-
fore substrate (Kanner and Bendahan, 1982), though the
sites may or may not be closely related. To determineFigure 5. Substrates and Inhibitors Prevent Modification of the
whether sodium interacts with residues P392 throughA395C Residue: The Temperature Dependence of Protection by
Q415, we evaluated the reactivity of the cysteine substi-Substrates
tution mutants with MTS derivatives in the presence and(A) The A395C carrier was incubated with 0.25 mM MTSEA and
L-Glu concentrations ranging from 0.01 mM to 10 mM. Data are absence of extracellular sodium. Only E406C (Figure 6A)
plotted as the percent inhibition of L-Glu uptake as a function of and Y405C (Figure 6B) show altered modification rates
the L-Glu concentration present during the MTSEA incubation. The when sodium is replaced with equimolar choline and
concentration of L-Glu that protects 50% of the transport activity
only with MTSEA but not MTSES or MTSET.(EC50 5 35 mM 6 5 mM; n 5 3) is approximately the same as the
COS-7 cells expressing the E406C transporter wereapparent affinity of this transporter for L-Glu (Km 5 37 mM 6 3 mM;
incubated with concentrations of MTSEA ranging fromn 5 9).
(B) The A395C carrier was incubated with 10 mM MTSES and DL- 0.05 mM to 2.5 mM in the presence of either sodium or
TBOA concentrations ranging from 0.01 mM to 1 mM. Data are choline. As shown in Figure 6A, MTSEA had a signifi-
plotted as the percent inhibition of L-Glu uptake as a function of cantly greater effect on transport in 120 mM choline.
the DL-TBOA concentration present during the MTSES incubation. The second order rate constant was increased z6-fold
The EC50 of DL-TBOA (29 mM 6 8 mM; n 5 3) to protect A395C is
(kcholine 5 3.0 6 0.6 M21s21; n 5 2 and ksodium 5 0.51 6similar to the apparent affinity of DL-TBOA to inhibit L-Glu transport
0.08 M21s21; n 5 2), and the concentration of MTSEAby this carrier (19 mM 6 4 mM; n 5 2).
(C) MTSES (10 mM) was incubated with COS-7 cells expressing the that resulted in a 50% inhibition of the transport activity
A395C transporter for time periods ranging from 0 s to 360 s in the was decreased from z5 mM to ,1 mM.
presence (open symbols) and absence (closed symbols) of 10 mM With the Y405C transporter, only a small increase in
L-Glu and at two temperatures: 228C (squares) and 28C±48C (circles). the modification rate was observed in the absence of
The data are plotted as the fraction of L-Glu uptake remaining as a
sodium (data not shown). Because the reaction rate isfunction of time. Data are the means 6 SD of two independent
dependent on both the reaction time and the concentra-experiments. Second order rate constants are 0.80 6 0.05 M21s21
tion of reagent, we explored this small increase by mea-(closed squares), 0.21 6 0.03 M21s21 (open squares), 0.047 6 0.009
M21s21 (closed circles), and 0.033 6 0.003 M21s21 (open circles). suring the rate as a function of time, at two different
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Figure 7. Topological Model of the Region P392 through Q415 in
EAAT1
Residues that when substituted to cysteine react with all three MTS
derivatives are black, those that react only with MTSEA are white,
those that did not react significantly with the MTS derivatives are
gray, and those that result in a nonfunctional transporter are striped.
Slotboom et al., 1996; Wahle and Stoffel, 1996) sug-
gested that this domain would be predominantly mem-
brane associated. Interestingly, we observed that MTSEA,
a compound known to react only with residues in an
aqueous environment, inhibited the transport activity of
nearly all of the cysteine substitutions (Figure 2A). This
Figure 6. Sodium Affects the Rate of MTSEA Modification result combined with our findings on the reactivity of
(A) Cells transiently expressing the E406C transporter were incu- other cysteine-substituted residues is more consistent
bated with concentrations of MTSEA ranging from 0 mM to 5 mM with a model in which this region lines an aqueous pore
in buffer containing 120 mM of either sodium (closed squares) or within the membrane. In addition, the pattern of reactiv-
choline (open squares). Data are plotted as the fractional inhibition
ity suggests a nonperiodic secondary structure. Al-of L-Glu transport as a function of the MTSEA concentration. Data
though one cannot exclude a b-stranded or an a-helicalare the means 6 SEM of three experiments done in triplicate. Second
conformation, the accessibility pattern makes it highlyorder rate constants are 3.0 6 0.6 M21s21 (choline) and 0.51 6 0.01
M21s21 (sodium). unlikely that this region exists in either of these confor-
(B) Cells transiently expressing the Y405C transporter were incu- mations with one side facing into a pore. If that were
bated with 0.5 mM (closed symbols) or 1 mM (open symbols) MTSEA the case, then every other residue (b strand) or every
for times ranging from 60 s to 600 s in the presence of sodium
third or fourth residue (a helix) would have been acces-(triangles) or choline (squares). Data are the means of two indepen-
sible.dent experiments performed in triplicate. Second order rate con-
Two residues located at opposite ends of the domain,stants are 2.4 6 0.4 M21s21 (choline) and 0.5 6 0.1 M21s21 (sodium)
at 0.5 mM MTSEA and 4.6 6 0.1 M21s21 (choline) and 2.67 6 0.01 A395C and A414C, react with the impermeant com-
M21s21 (sodium) at 1 mM MTSEA. pounds MTSET (Figure 2C) and MTSES (Figure 2D). Ad-
ditionally, their modification rates with MTSEA are the
highest when compared to the other residues, sug-
gesting that they are quite accessible. Thus, both resi-concentrations of MTSEA (0.5 mM and 1 mM) and in
dues are likely positioned near the extracellular sidethe presence of either sodium or choline. Under these
of the membrane (Figure 7). A lower concentration ofconditions, replacement with choline significantly in-
MTSEA (1 mM) still inhibits the functional mutants clus-creased the reaction rate at both concentrations of
tered around the A395C residue (P392C through I397C),MTSEA, suggesting that sodium also retards the modifi-
as well as the more centrally located Y405C residue,cation of this residue (Figure 6B). The fractional inhibition
but does not inhibit the mutants A403C through A410C,of transport observed for the A395C and A414C carriers
which are also near the center of this domain (Figureafter application of submaximal concentrations of MTSES
2B). The reduced reactivity of these latter residues is(5 mM) or MTSET (0.5 mM) did not change with sodium
consistent with their placement deeper within a crevice,replacement (data not shown).
so that they are sterically and possibly electrostically
less reactive with extracellularly applied MTSEA. Y405
may be accessible to both the extracellular and intracel-Discussion
lular environments (Figure 7) as has been suggested by
studies that implicate the analogous residue in GLT-1Our studies suggest a model for the topological organi-
zation of the region from P392 through Q415 based on in the binding of internal potassium ions (Zhang et al.,
1998). MTSEA can permeate the membrane in its un-the accessibility of these residues to the various MTS
reagents in functional, surface-expressed transporters. charged form and thus under some conditions could
react with residues from either side of the membraneAnalysis of hydropathy profiles as well as several pro-
posed topological models (Jording and Puhler, 1993; (Holmgren et al., 1996). We have shown in COS-7 cells
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that MTSEA gains access to the intracellular side of the conductances (reviewed in Lester et al., 1994; DeFelice
and Blakely, 1996; Sonders and Amara, 1996). Thus,membrane and reacts with a cysteine substituted in a
known cytoplasmic domain in the C terminus of EAAT1 although solute-dependent transporters translocate
substrates and coupled ions with a fixed stoichiometry,(R. P. S., unpublished). Thus, inhibition of some cysteine
mutants with MTSEA may be explained by modification many of these carriers also appear to mediate the flux
of uncoupled ions in a manner similar to ion channels.from the cytoplasmic side of the membrane.
Together, these data support the idea that this region Based on these findings, mechanistic models of solute-
dependent transporters have expanded from simple al-forms a reentrant loop that may be part of a translocation
pore for substrates and cotransported ions. A similar ternating-access models to ones that also incorporate
gating mechanisms and pore domains akin to those intopology was proposed for this domain in a study using
microsomal membranes to examine the folding of trun- ion channels (Cammack and Schwartz, 1996; Lester et
al., 1994; DeFelice and Blakely, 1996; Sonders andcations of GLAST-1 (rat homolog of EAAT1) fused to a
glycosylation reporter domain. Wahle et al. (1996) pro- Amara, 1996; Su et al., 1996). The presence of a reentrant
loop in this family of carriers is consistent with the exis-posed that the region is reentrant but was modeled as
two b strands within the membrane. Evidence was not tence of a channel-like pore that could mediate the
translocation of substrates and/or the flux of ions.yet available, however, to experimentally confirm this
secondary structure or to implicate it in the formation
of a pore. Protection of the A395C Residue Is Independent
of Substrate TranslocationIn a recent report, the membrane orientation of individ-
ual cysteine residues substituted into the GLT-1 trans- Several experiments suggest the involvement of this
domain in substrate binding and/or translocation. Analy-porter was evaluated using thiol-specific modifying re-
agents (Grunewald et al., 1998). The results of this study sis of the A395C residue revealed that L-Glu protects
the residue from modification by MTSES, MTSET, andwere the basis for a model with seven a-helical TMs,
followed by three shorter membrane-associated seg- low concentrations of MTSEA with an affinity that is
similar to its apparent transport affinity (Figure 5A). Thisments and ending with an eighth a-helical TM. This
model interprets the region of our proposed P loop as could occur because the binding of L-Glu blocks access
of the reagents to the cysteine side chain or because ita membrane spanning a helix (TM7) with the preceding
residues as intracellular. Our data contradict this aspect stabilizes a particular conformation that restricts access
to the side chain. Biochemical evidence for substrate-of the model because we have shown here in a functional
assay that A395C in EAAT1, which would correspond induced conformational changes in the N-terminal half
of GLT-1 has been obtained by comparing the size ofto the cytoplasmic side of the putative GLT-1 TM7, can
be readily modified with the membrane-impermeant re- transporter fragments generated by limited proteolysis
in the presence and absence of substrates (Grunewaldagents MTSES and MTSET (Figure 2). In addition, a
larger molecule, MTSEA-biotin, labels A395C, and this and Kanner, 1995).
Nontransported, competitive inhibitors are thought toreaction can be blocked by MTSES and MTSET (data
not shown). Moreover, we have found that the transport bind to similar sites as substrates, but not to induce
a complete transport cycle. Although DL-TBOA is notactivity of two cysteine mutants made in the EAAT1
domain analogous to the putative intracellular loop be- transported, it may induce or stabilize particular confor-
mations upon binding the carrier, as shown with kainate,fore TM7 can be abolished by the extracellular applica-
tion of the membrane-impermeant reagents MTSES and a nontransported, competitive inhibitor that appears to
increase the accessibility of the Y403C residue in GLT-1MTSET (data not shown). Together, these data argue
that at least a portion of the region before P392 faces the (Zarbiv et al., 1998). Thus, the ability of DL-TBOA to
protect the A395C residue from modification by MTSESextracellular milieu, consistent our model of a reentrant
loop for this domain. The reason for the differences in (and MTSET, but not MTSEA; data not shown) with an
affinity similar to its affinity to block the transport ofthe two models is not clear but may reflect differences
in the experimental approaches used. L-Glu (Figure 5B) suggests that protection of the residue
is similar to that observed with L-Glu and takes placeReentrant loops have been postulated for a number
of ion channels (reviewed in MacKinnon, 1995), including prior to substrate translocation.
Measurement of transport rates at lowered tempera-the M2 segment of ionotropic glutamate receptors (Holl-
mann et al., 1994; Wo and Oswald, 1994; Bennett and tures has been used to distinguish substrate binding
from translocation because the transport of substratesDingledine, 1995), the P loop of cyclic nucleotide-gated
channels (Sun et al., 1996), and the P loop of voltage- appears to be highly temperature dependent, whereas
the binding of substrates remains unaffected (Wadichegated potassium (Yellen et al., 1991) and sodium chan-
nels (Sather et al., 1994; Perez-Garcia et al., 1996). X-ray and Kavanaugh, 1998). The finding that L-Glu protects
the A395C residue at temperatures where transportcrystallographic analysis of an S. lividans potassium
channel, which has similarity in both sequence and func- does not occur (Figure 5C) also supports the idea that
substrates block the modification at a step prior to sub-tion to the mammalian voltage-gated potassium chan-
nels, provides additional evidence that residues of such strate translocation. The results from these experiments
are again consistent with the idea that protection ofP loops participate in forming the aqueous pore and
selectivity filter for ions (Doyle et al., 1998). Many exam- the residue occurs at a step closely linked to substrate
binding, but independent of translocation, and couldples in both recombinant and in vivo systems illustrate
that transporters mediate both substrate-gated ion con- support a model in which the A395C residue lies near
a glutamate-binding site.ductances as well as substrate-independent (ªleakº)
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The A395C residue was not protected by L-Glu when type may influence the binding of sodium and/or potas-
sium ions to the glutamate transporters as well. BecauseMTSEA was applied at concentrations greater than ap-
proximately 2 mM (Figure 4). It could not be determined the modification rates of these residues with MTSEA are
increased in the absence of extracellular sodium ions,whether covalent attachment of MTSEA effectively com-
petes with the reversible binding of L-Glu from the extra- we propose that they reside within an aqueous translo-
cation pore and are positioned such that they can becellular side of the membrane or if MTSEA reacts with
the residue using an alternative route that involves cross- accessed from the extracellular milieu (Figure 7).
In conclusion, this study provides evidence that resi-ing the cell membrane. The latter explanation seems more
likely because L-Glu can still protect the A395C residue dues P392 through Q415 of EAAT1 are important to
several aspect of transporter structure and function. Thefrom modification by the membrane-impermeant re-
agents MTSES and MTSET at concentrations that are existence of a reentrant membrane loop with both ends
exposed to the extracellular milieu suggests that, byeffectively greater than 2.5 mM MTSEA once the reactiv-
ity rates have been normalized. Thus, the A395C residue, analogy to the P loops of ion channels, this domain may
participate in the formation of an aqueous translocationlike Y405C, may be modified by MTSEA from either side
of the membrane. pore. Examination of other domains in the carrier by
SCAM should bring insight into the tertiary structure of
the carrier and provide a more detailed model of theThe Ala-414 Residue May Reside at the Entrance
structural determinants underlying the translocation andof a Translocation Pore
ion flux processes executed by these molecules.Another intriguing observation is that the transport inhi-
bition observed with modifications of A414C roughly
Experimental Procedures
correlates with the size of the added substituent group
(Figure 3). Modification by bulky MTS derivatives, MTSES Construction of the Cys(2) and Single Cysteine Carriers
A Cys(2) transporter was engineered by making conservative sub-(negative charge), MTSET (positive charge), or the large
stitutions of the three endogenous cysteine residues in the EAAT1MTSACE (neutral) resulted in dramatically reduced
transporter (C186S, C252A, and C375G), using the Altered Sites IItransport activity, whereas the smaller MTSEA (positive
site-directed mutagenesis kit and recommended protocol (Pro-charged) or MMTS (neutral) reagents resulted in only
mega, Madison, WI). Cys(2) was sequenced on both strands and
minor inhibition. Because all of the MTS derivatives re- subcloned into pOTV for expression in Xenopus oocytes and into
acted to completion with this residue, it is likely that pCMV5 for expression in COS-7 cells (Arriza et al., 1994). Single
cysteine carriers were made using a PCR-based mutagenesis strat-MTSEA and MMTS exert a limited effect on the transport
egy. Two primers were designed to flank the mutagenesis region.activity of the carrier because they introduce smaller
One was made to a unique PstI restriction site in the 59 end of thesubstituents. Inhibition by the MTS derivatives could
coding sequence (59PstI), and the other one to the last nucleotidesarise from a decrease in the ability of L-Glu or sodium
of the coding sequence and included an XbaI site (39XbaI). Twenty-
ions to bind to the carrier or from steric limitations placed four mutant primers were designed to substitute each residue in
on conformational changes required for substrate trans- the region P392 through Q415 with cysteine. For each reaction, 1
mg each of the 59PstI, 39XbaI, and a mutant primer were added toport. In the scheme shown in Figure 7, we position
a tube containing 10 U of Vent polymerase, 10 U of Taq thermostableA414C at the extracellular entrance of a translocation
ligase (both from New England Biolabs, Beverly, MA), 0.25 mM ofpore formed by this region of the carrier, to reflect its
each of dATP, dCTP, dGTP, dTTP, 13 Taq thermostable ligaseaccessibility to all MTS derivatives tested and to position
buffer, and 100 ng of the Cys(2)OTV plasmid in a final volume of
it where it could interfere with the access of substrates 100 ml. Cycling conditions were: 958C for 5 min (1 cycle), 958C for
or cotransported ions when it is modified by MTS deriva- 30 s, 508C for 30 s, 658C for 10 min (25 cycles), and a 15 min
final extension at 658C. The 1.2 kb products were subcloned intotives of sufficient size.
Cys(2)OTV and Cys(2)CMV5 plasmids using the PstI and XbaI sites
and sequenced by Dye Terminator Cycle Sequencing (ABI PRISM,
Accessibility of Two Residues Is Influenced Perkin Elmer).
by Extracellular Sodium Ions
Functional Characterization of the Cys(2) and SingleSCAM analysis also revealed that extracellular sodium
Cysteine Transportersions limit the modification of cysteine substitutions at
Transport affinity values (Km) for L-Glu uptake into COS-7 cells wereY405 and at E406 (Figure 6). This may occur by direct
determined for each carrier. Cells were transiently transfected using
occlusion, or alternatively by stabilizing a conformation the DEAE-dextran method, and 48 hr later a radiolabeled L-Glu trans-
that restricts access to the side chain. A similar decrease port assay was performed, as previously described (Arriza et al.,
1994). Km values were derived by nonlinear regression analysis (Ka-in the accessibility of Y403C and E404C in GLT-1 to
leidagraph, Synergy Software, Reading, PA).MTSEA in the presence of external sodium ions was
A two-electrode voltage clamp was used in Xenopus oocytes toobserved (Zarbiv et al., 1998). Although we have not
measure the transport affinity (EC50) (260 mV) and current±voltageobserved MTSET modification of Y405C in EAAT1, it
relationships for L-Glu from substrate-elicited steady state currents
does appear to react with the Y403C mutant of GLT-1 as described previously (Arriza et al., 1997).
(Zarbiv et al., 1998). In earlier site-directed mutagenesis
studies of GLT-1, aromatic substitutions at the Y403 Cell Surface Expression Levels of the Carriers in COS-7 Cells
Cell surface expression of transiently transfected transporters wasposition altered the ion dependence and the increased
assayed as previously described (Daniels and Amara, 1998). Briefly,affinity of sodium binding to the carrier (Zhang et al.,
cells were washed with PBS and then incubated with 1.5 mg/ml1998). It has been hypothesized that the quadrupole
NHS-biotin (Pierce, Rockford, IL) in PBS for 40 min at 48C. A glycine-
moment of aromatic amino acids influence the binding containing buffer was used to quench the reaction. Cells were lysed
of cations in some channels by a weak electrostatic on ice with a 1% Triton X-100 buffer, transferred to a 1.5 ml micro-
fuge tube and spun at 14,000 rpm. Ultralink Immobilized NeutrAvidin
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beads (Pierce, Rockford, IL) were added to the supernatants, and Akabas, M.H., Kaufmann, C., Archdeacon, P., and Karlin, A. (1994).
Identification of acetylcholine receptor channel-lining residues inthe components were mixed overnight at 48C. The beads were then
washed, 23 SDS loading buffer was added, and the sample was the entire M2 segment of the a subunit. Neuron 13, 919±927.
incubated at 378C for 30 min. The proteins were separated on an Arriza, J.L., Fairman, W.A., Wadiche, J., Murdoch, G.H., Kavanaugh,
8.5% polyacrylamide gel, transferred to Immobilon-P (Millipore M.P., and Amara, S.G. (1994). Functional comparisons of three gluta-
Corp., Bedford, MA), probed with a polyclonal antibody raised to mate transporter subtypes cloned from motor cortex. J. Neurosci.
the C terminus of EAAT1 (1:3,000 dilution), and visualized with a 14, 5559±5569.
horseradish peroxidase (HRP)-conjugated secondary antibody Arriza, J.L., Eliasof, S., Kavanaugh, M.P., and Amaras, S.G. (1997).
(1:10,000; Amersham, Arlington Heights, IL) and chemiluminescent Excitatory amino acid transporter 5, a retinal glutamate transporter
detection (Dupont NEN, Boston, MA). coupled to a chloride conductance. Proc. Natl. Acad. Sci. USA 94,
4155±4160.
Application of MTS Derivatives and Measurement
Bennett, J.A., and Dingledine, R. (1995). Topology profile for a gluta-of the Transport Activity in COS-7 Cells
mate receptor: three transmembrane domains and a channel-liningMTS derivatives (Toronto Research Chemicals Inc.) were solublized
reentrant membrane loop. Neuron 14, 373±384.in water as 503 stocks immediately prior to use. Cells were washed
Bolton, E., Higginsson, B., Harrington, A., and O'Gara, G. (1986).once with PBS before the MTS derivatives were added to their final
Dicarboxylic acid transport in Rhizobium Meliloti: isolation of mu-concentrations. To compensate for the different rates of covalent
tants and cloning of dicarboxylic acid transport genes. Arch. Micro-modification with free sulfhydryls in solution, the MTS derivatives
biol. 144, 142±146.were applied in most experiments at the following concentrations:
2.5 mM MTSEA, 10 mM MTSES, and 1 mM MTSET (Stauffer and Cammack, J.N., and Schwartz, E.A. (1996). Channel behavior in a
Karlin, 1994). Unless otherwise stated, in all experiments incubations g-aminobutyrate transporter. Proc. Natl. Acad. Sci. USA 93,
with MTS derivatives were done at room temperature for 5 min. 723±727.
Following the incubation, cells were washed three times with PBS Daniels, G.M., and Amara, S.G. (1998). Selective labeling of neuro-
and assayed for uptake of 10 mM radiolabeled L-Glu (9.9 mM nonla- transmitter transporters at the cell surface. In Methods in Enzymol-
beled L-Glu and 100 nM [3H]-L-Glu [24 Ci/mmol]; 10 min at room ogy, Vol. 296, Susan G. Amara, ed. (San Diego, California: Academic
temperature). Press), 307±318.
The effect of the MTS derivatives on uptake is expressed as either
DeFelice, L.J., and Blakely, R.D. (1996) Pore models for transport-
the percent inhibition [PI 5 100 2 (100 3 uptake after/uptake before)]
ers? Biophys. J. 70, 579±580.
or the fraction of uptake remaining (F 5 uptake after/uptake before).
Diamond, J.S., and Jahr, C.E. (1997). Transporters buffer synapti-Second order rate constants (k) were calculated by plotting F as a
cally released glutamate on a submillisecond time scale. J. Neurosci.function of time (t) in s or of concentration of MTS derivative (c) in
17, 4672±4687.moles/liter and then fitting the data to the equation: F 5 exp(2ktc),
Dougherty, D.A. (1996). Cation-pi interactions in chemistry and biol-in the case where F goes to zero at very large t or c. Otherwise,
ogy: a new view of benzene, Phe, Tyr, and Trp. Science 271, 163±168.the data were fitted to the equation F 5 Fmax 3 exp(2ktc) 1 Fmin.
Significance was determined by one-way ANOVA (p , 0.05) using Doyle, D.A., Cabral, J.M., Pfuetzner, R.A., Kuo, A., Gulbis, J.M.,
statistical software (SPSS, Inc., Chicago, IL). Cohen, S.L., Chait, B.T., and MacKinnon, R. (1998). The structure
To examine the effects of sodium on sulfhydryl modification, cells of the potassium channel: molecular basis of K1 conduction and
were washed one time with KRH buffer containing either sodium selectivity. Science 280, 69±77.
chloride or choline chloride (each at 120 mM). MTS derivatives were Eliasof, S., and Werblin, F. (1993). Characterization of the glutamate
incubated in the same buffer. After the incubation, the cells were transporter in retinal cones of the tiger salamander. J. Neurosci. 13,
washed one time with the corresponding buffer and then two times 402±411.
with PBS.
Fairman, W.A., Vandenberg, R.J., Arriza, J.L., Kavanaugh, M.P., andFor experiments in which DL-TBOA or nonlabeled L-Glu was in-
Amara, S.G. (1995). An excitatory amino-acid transporter with prop-cluded in the reaction, the compounds were added 2 min prior to
erties of a ligand-gated chloride channel. Nature 375, 599±603.the MTS derivatives. The percent inhibition of uptake was plotted
Grunewald, M., and Kanner, B. (1995). Conformational changesas a function of the L-Glu or DL-TBOA concentration and fitted to
monitored on the glutamate transporter GLT-1 indicate the exis-the Michaelis-Menten equation using nonlinear regression analysis
tence of two neurotransmitter-bound states. J. Biol. Chem. 270,to determine the half-maximal concentration (EC50) that protects the
17017±17024.residue from modification (Kaleidagraph).
To examine the effect of low temperature on protection by sub- Grunewald, M., Bendahan, A., and Kanner, B.I. (1998). Biotinylation
strate, cells were placed on ice and then washed twice with ice cold of single cysteine mutants of the glutamate transporter GLT-1 from
PBS. L-Glu was added, followed 2 min later by the modifying reagent. rat brain reveals its unusual topology. Neuron 21, 623±632.
After 5 min, the cells were washed one time with ice cold PBS and Hollmann, M., Maron, C., and Heinemann, S. (1994). N-glycosylation
two times with PBS at room temperature. Radiolabeled uptake of site tagging suggests a three transmembrane domain topology for
L-Glu was assayed as described. the glutamate receptor GluR1. Neuron 13, 1331±1343.
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